Rapport Therapeutics, Inc. Common StockRAPPNASDAQ
LOADING
|||
Cash Flow Under Pressure
Trending lower, below historical average, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-67.23M
↓ 103% below average
Average (2y)
$-33.19M
Historical baseline
Range
High:$-3.53M
Low:$-67.23M
CAGR
+336.7%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-67.23M | -133.3% |
| 2023 | $-28.82M | -717.3% |
| 2022 | $-3.53M | - |